Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
GG.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GG.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.3.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FL.3.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.3.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FL.3.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FL.3.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FL.3.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FL.3.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.3.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CK.1.5EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
CK.1.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CK.1.5ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
CK.1.5ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
CK.1.5EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
CK.1.5EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
CK.1.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CK.1.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.34EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.5.34EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.34ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.5.34ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.5.34EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.5.34EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.5.34ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.34ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GD.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
GD.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
GD.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
GD.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-3196.01Germany
GD.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
GD.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-3384China
GD.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GD.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
XBB.1.37.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.37.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.37.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.37.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.37.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.37.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.37.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.37.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.77EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.5.77EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.77ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.5.77ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.5.77EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.5.77EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.5.77ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.77ENiu-ECACGTTAACAATATTGCAGC20402639126372R-12869.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used